Bailey TS, Gill J, Jones M, Shenoy L, et al. Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to GLP-1 RA therapy in people with type 2 diabetes: The DELIVER-G study. Diabetes Obes Metab 2022 May 1. doi: 10.1111/dom.14739.
PMID: 35491520